Patrick Leavey, M.D.

Biography

Patrick Leavey, M.D., graduated from the Royal College of Surgeons in Ireland in 1986. He spent 4 years in Ireland as a junior house officer (Internal Medicine and Pediatrics), 2 years at Princess Margaret Hospital in Perth, Western Australia as a pediatric registrar and then came to the US to do his pediatric hematology/oncology fellowship at The Children’s Hospital Denver and University of Colorado Health Sciences Center in 1992. Dr. Leavey worked in the lab of Daniel Ambruso, M.D. for 4 years on projects related to the influence of G-CSF on granulocyte function and the exploration and identification of a novel neutrophil cytosolic protein.

Dr. Leavey joined the pediatric faculty at UT Southwestern Medical Center in 1998 where he is currently a Professor of Pediatrics and a Pediatric Oncologist at Children’s Health, Children’s Medical Center Dallas and Plano.

During his years of training Dr. Leavey became a member of the Royal College of Physicians of Ireland, a Fellow of the Royal Australasian College of Physicians and a Diplomate of Child Health from the National University of Ireland. He was granted a Doctorate in Medicine from the National University of Ireland, based on his work in the Ambruso laboratory. He is subspecialty board certified in Pediatric Hematology/Oncology by the American Board of Pediatrics.

Currently Dr. Leavey holds several leadership positions both regionally and nationally. He is the Associate Vice Chair for Research Operations at the Department of Pediatrics, and the Associate Director for Clinical research for the Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center Dallas. Dr. Leavey is the Immediate Past President of the Active Medical / Dental Staff at Children's Medical Center Dallas and past President of the American Society of Pediatric Hematology/Oncology. At the Children’s Oncology Group (COG), Dr. Leavey was a long-standing member of the Bone Sarcoma Steering Committee up to 2023. Dr. Leavey continues to serve on medical advisory boards for the Children’s Cancer Fund and The Clayton Dabney Foundation.

Dr. Leavey hold several key positions in clinical and translational research. He is the co-chair for the COG study AOST2031, a co-investigator for a CPRIT funded study of whole slide imaging in pediatric rhabdomyosarcoma and the principal investigator for a Team Connor Foundation award to study machine learning tools in osteosarcoma. Dr. Leavey is also the site PI for an American Society of Hematology Award, establishing the North Texas Sickle Cell Disease Clinical Trial Unit.